Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 1.000 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.645 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.609 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.605 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.604 | |
4wbo | ANW | Rhodopsin kinase | / | 0.584 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.563 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.559 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.558 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.557 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.556 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.555 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.554 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.553 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.548 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.547 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.546 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.544 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.543 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.543 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.542 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.542 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.542 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.541 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.540 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.540 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.540 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.539 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.537 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.536 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.535 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.533 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.533 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.533 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.533 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.532 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.531 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.530 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.530 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.530 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.529 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.529 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.529 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.528 | |
2vtj | LZ4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.527 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.526 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.526 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.526 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.525 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.524 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.523 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.523 | |
3c4x | ATP | Rhodopsin kinase | / | 0.523 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.523 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.522 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.522 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.522 | |
1dm2 | HMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.521 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.521 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.521 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.521 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.521 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.521 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.521 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.520 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.519 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.519 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.518 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.518 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.517 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.517 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.516 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.516 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.516 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.516 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.516 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.515 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.515 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.515 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.514 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.514 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.514 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.514 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.514 | |
3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.513 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.513 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.513 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.513 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.512 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.512 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.512 | |
1pye | PM1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.511 | |
2vag | V25 | Dual specificity protein kinase CLK1 | 2.7.12.1 | 0.511 | |
4j71 | 1JX | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.511 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.511 | |
4n6z | 2HW | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.511 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.510 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.510 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.510 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.509 | |
1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.509 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.509 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.509 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.509 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.509 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.509 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.509 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.509 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.509 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.508 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.508 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.508 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.508 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.508 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.508 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.508 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.508 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.507 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.507 | |
3rk9 | 09Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.507 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.507 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.507 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.507 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.507 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
2euf | LQQ | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.506 | |
3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.506 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.506 | |
4euf | NAD | Trans-2-enoyl-CoA reductase [NADH] | / | 0.506 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.506 | |
1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.505 | |
1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.505 | |
3blr | CPB | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.505 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.505 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.505 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.505 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.505 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.504 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.504 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.504 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.504 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.504 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
2r3l | SCW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.503 | |
2uzo | C62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.503 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.503 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.503 | |
3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.503 | |
4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.503 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.502 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.502 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.502 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
3t8o | ATP | Rhodopsin kinase | / | 0.502 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.502 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.502 | |
4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.502 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.502 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.501 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.501 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.501 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.501 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.501 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.501 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.501 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.501 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.501 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.501 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.500 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.500 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.500 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.500 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.500 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
3qtz | X42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
3vf9 | 477 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.499 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.499 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.498 | |
2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.498 | |
3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.498 | |
4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.498 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.498 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.497 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.497 | |
3qqf | X07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.497 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.497 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.496 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.496 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
3s0o | 50Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.496 | |
4e93 | GUI | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.496 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.496 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.496 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.496 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.495 | |
2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.495 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.495 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.495 | |
3roy | 22Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.495 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.495 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.495 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.494 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.494 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.494 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.494 | |
4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.494 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.493 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.493 | |
2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.493 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.493 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.492 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.492 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.492 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.492 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.492 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.492 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
1cqp | 803 | Integrin alpha-L | / | 0.491 | |
1v0o | INR | Cell division control protein 2 homolog | 2.7.11.22 | 0.491 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.491 | |
2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.491 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.491 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.491 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.491 | |
3r6x | X84 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.491 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.491 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.491 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.491 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.491 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.490 | |
1ke9 | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.490 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.490 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.490 | |
3mtl | FEF | Cyclin-dependent kinase 16 | 2.7.11.22 | 0.490 | |
3qf9 | NM8 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.490 | |
3tku | M77 | Serine/threonine-protein kinase MRCK beta | 2.7.11.1 | 0.490 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.490 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.490 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
2pzi | AXX | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.489 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.489 | |
3jpv | 1DR | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.489 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
3r9o | Z71 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.489 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.489 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.489 | |
4qmu | SKE | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.489 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.489 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.488 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.488 | |
3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.488 | |
3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.488 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.488 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.488 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.488 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.487 | |
1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.487 | |
2r3k | SCQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.487 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.487 | |
3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.487 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.487 | |
3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.487 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.487 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.487 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.487 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.486 | |
2c3i | IYZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.486 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.486 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.486 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.486 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.486 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.486 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.486 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
3uix | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.486 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.486 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.485 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.485 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.485 | |
4fkj | 11K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
1rx1 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.484 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.484 | |
3f88 | 3HT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.484 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.484 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.484 | |
3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.484 | |
3q5i | ANP | Protein kinase, putative | / | 0.484 | |
3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.484 | |
3qls | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.484 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.484 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.484 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.484 | |
4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.484 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.484 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.483 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.483 | |
3qtq | X35 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
3ti1 | B49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.483 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.483 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.483 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.483 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.483 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.483 | |
1ra3 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.482 | |
1rfu | ADP | Pyridoxal kinase | 2.7.1.35 | 0.482 | |
1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.482 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.482 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.482 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.482 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.482 | |
4fks | 46K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
4ix6 | ADP | Uncharacterized protein | / | 0.482 | |
1kl2 | FON | Serine hydroxymethyltransferase | / | 0.481 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.481 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.481 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
2bhh | RYU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
2vth | LZ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.481 | |
3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3r7e | X88 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.481 | |
4j1r | I5R | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.481 | |
1v79 | FR7 | Adenosine deaminase | 3.5.4.4 | 0.480 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.480 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.480 | |
2hma | SAM | tRNA-specific 2-thiouridylase MnmA | / | 0.480 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.480 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.480 | |
3rjc | 06Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.480 | |
4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.480 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.480 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.480 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.480 | |
1t86 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.479 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2xnb | Y8L | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.479 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
3wbl | PDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.479 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.479 | |
4ewh | T77 | Activated CDC42 kinase 1 | / | 0.479 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.479 | |
4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.479 | |
1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.478 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.478 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.478 | |
3sw4 | 18K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
3tqa | NDP | Dihydrofolate reductase | / | 0.478 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.478 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.478 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.477 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.477 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.477 | |
3r28 | XA0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.477 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.477 | |
6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.477 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.476 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.476 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.476 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.476 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.476 | |
2xiz | XIZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.476 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.476 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.476 | |
4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.476 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.476 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.476 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.476 | |
4z64 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.476 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.476 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
1rx8 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.475 | |
1th6 | OIN | Basic phospholipase A2 VRV-PL-VIIIa | 3.1.1.4 | 0.475 | |
1zlt | HYM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
2b54 | D05 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
2bkz | SBC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.475 | |
2qkr | IXM | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.475 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.475 | |
3c50 | ADP | Rhodopsin kinase | / | 0.475 | |
3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.475 | |
3gbu | ATP | Uncharacterized sugar kinase PH1459 | 2.7.1 | 0.475 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.475 | |
3r1q | X75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.475 | |
4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.475 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.475 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.475 | |
1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.474 | |
1me8 | RVP | Inosine-5'-monophosphate dehydrogenase | / | 0.474 | |
1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
2aqi | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.474 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.474 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.474 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.474 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
4eom | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.474 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.474 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.473 | |
2b37 | 8PS | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.473 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
2vti | LZ3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.473 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.473 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.473 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.473 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.473 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.473 | |
3vf8 | 0JE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.473 | |
3wrl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.473 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.473 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.472 | |
1r0e | DFN | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.472 | |
2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.472 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.472 | |
2vtl | LZ5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
3so9 | 017 | Pol protein | / | 0.472 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.472 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.472 | |
4ruj | VDX | Vitamin D3 receptor A | / | 0.472 | |
4xhg | ADP | Uncharacterized protein | / | 0.472 | |
1p44 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.471 | |
1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.471 | |
2b00 | GCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.471 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.471 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
2uzn | C96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.471 | |
3d84 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.471 | |
3gob | HXX | DdmC | / | 0.471 | |
3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.471 | |
3qzf | X66 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.471 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.471 | |
4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.471 | |
4nbw | NAD | Short-chain dehydrogenase/reductase SDR | / | 0.471 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.471 | |
4q5h | ANP | Protein kinase OspG | 2.7 | 0.471 | |
5ecc | NAP | Dehydrofolate reductase type I | / | 0.471 | |
5fwn | NAP | Putative dehydrogenase | / | 0.471 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.470 | |
2bhe | BRY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.470 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.470 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.470 | |
3r8z | Z63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.470 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.470 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.470 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.469 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.469 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.469 | |
3kc3 | MK2 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.469 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.469 | |
3unk | 0BY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
1drh | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.468 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.468 | |
1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.468 | |
2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.468 | |
2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.468 | |
2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.468 | |
2vn9 | GVD | Calcium/calmodulin-dependent protein kinase type II subunit delta | 2.7.11.17 | 0.468 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.468 | |
3qn8 | NI7 | Gag-Pol polyprotein | 3.4.23.16 | 0.468 | |
3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.468 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.468 | |
5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.468 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.468 | |
1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.467 | |
1n4h | REA | Nuclear receptor ROR-beta | / | 0.467 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.467 | |
1urw | I1P | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2aq8 | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.467 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
2zv2 | 609 | Calcium/calmodulin-dependent protein kinase kinase 2 | 2.7.11.17 | 0.467 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.467 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.467 | |
3hbb | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.467 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.467 | |
3pxy | JWS | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3qtr | X36 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.467 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.467 | |
4ez3 | 0S0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4gg5 | 0J3 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.467 | |
4nm0 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.467 | |
4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.467 | |
1dz4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.466 | |
1ke5 | LS1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
1lhv | NOG | Sex hormone-binding globulin | / | 0.466 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.466 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.466 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.466 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.466 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.466 | |
3fwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.466 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.466 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.466 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.466 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
4q73 | FAD | Bifunctional protein PutA | / | 0.466 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.466 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.465 | |
1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
1nhh | ANP | DNA mismatch repair protein MutL | / | 0.465 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
1uy7 | PU4 | Heat shock protein HSP 90-alpha | / | 0.465 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
2jko | BIJ | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
2oyf | IAC | Basic phospholipase A2 VRV-PL-VIIIa | 3.1.1.4 | 0.465 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.465 | |
3qts | X46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3r71 | X86 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3tm0 | ANP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.465 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.465 | |
4e20 | 0MY | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.465 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.465 | |
4mgi | CMP | Rap guanine nucleotide exchange factor 4 | / | 0.465 | |
4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.465 | |
4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.465 | |
1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.464 | |
2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.464 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.464 | |
3krw | BA1 | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.464 | |
3ql8 | X01 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.464 | |
4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.464 | |
4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.464 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.463 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
2vtn | LZ7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
3clb | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.463 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.463 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.463 | |
3l63 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.463 | |
3n0t | OPY | Dipeptidyl peptidase 2 | 3.4.14.2 | 0.463 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.463 | |
3qru | X19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.463 | |
4btm | F8E | Tau-tubulin kinase 1 | 2.7.11.1 | 0.463 | |
4g95 | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.463 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
5eyp | LOC | Tubulin beta chain | / | 0.463 | |
1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.462 | |
1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.462 | |
1qnf | FAD | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.462 | |
1xdd | AAY | Integrin alpha-L | / | 0.462 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
2wgj | VGH | Hepatocyte growth factor receptor | 2.7.10.1 | 0.462 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.462 | |
3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.462 | |
3c4w | ATP | Rhodopsin kinase | / | 0.462 | |
3fz1 | B98 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.462 | |
3nd1 | SAH | Precorrin-6A synthase (Deacetylating) | / | 0.462 | |
3ox1 | 695 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.462 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
4ek1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.462 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
4fko | 20K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.462 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.462 | |
4rcv | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.462 | |
5c8d | 5AD | Probable transcriptional regulator | / | 0.462 | |
1ia1 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
1klk | PMD | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
1ung | ALH | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.461 | |
1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.461 | |
2aqk | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.461 | |
2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.461 | |
2dhf | DZF | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.461 | |
2pmo | HMD | Protein kinase 7 | / | 0.461 | |
3iqe | H4M | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.461 | |
3ork | AGS | Serine/threonine protein kinase | / | 0.461 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3zvv | XAZ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.461 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.461 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.461 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.461 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.461 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.461 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
4qem | HC4 | Phospholipase A2 VRV-PL-VIIIa | / | 0.461 | |
4ruo | BIV | Vitamin D3 receptor A | / | 0.461 | |
1dds | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
1fpq | SAM | Isoliquiritigenin 2'-O-methyltransferase | / | 0.460 | |
1m2q | MNX | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.460 | |
2etk | HFS | Rho-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
2r3f | SC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
2wkm | PFY | Hepatocyte growth factor receptor | 2.7.10.1 | 0.460 | |
2xj2 | 985 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.460 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
3mb6 | 01I | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
3nbw | TR4 | Ketohexokinase | / | 0.460 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.460 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
3w0g | W07 | Vitamin D3 receptor | / | 0.460 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.460 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.460 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.460 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.459 | |
1iwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.459 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.459 | |
1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.459 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.459 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.459 | |
2vxo | XMP | GMP synthase [glutamine-hydrolyzing] | 6.3.5.2 | 0.459 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.459 | |
3dcv | 55E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.459 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
3qtw | X3A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3unj | 0BX | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.459 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.459 | |
4deg | 0JJ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.459 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.459 | |
4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.459 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.459 | |
4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
4l4a | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.459 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.459 | |
1ay0 | TPP | Transketolase 1 | 2.2.1.1 | 0.458 | |
1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.458 | |
1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
1m78 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
1qiw | DPD | Calmodulin | / | 0.458 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2e8t | IPE | Geranylgeranyl pyrophosphate synthase | / | 0.458 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.458 | |
2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.458 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.458 | |
3zls | 92P | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.458 | |
4a9h | TVP | Bromodomain-containing protein 2 | / | 0.458 | |
4aua | 4AU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.458 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.458 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.458 | |
4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.458 | |
4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.458 | |
1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.457 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.457 | |
1yrd | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.457 | |
2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.457 | |
2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.457 | |
3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.457 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.457 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.457 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.457 | |
4c59 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.457 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.457 | |
4g3r | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.457 | |
4g6o | E28 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
4ivc | 1J6 | Tyrosine-protein kinase JAK1 | / | 0.457 | |
4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.457 | |
4jvm | XDI | Estrogen sulfotransferase | 2.8.2.4 | 0.457 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.457 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
1dr5 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
1kkq | 471 | Peroxisome proliferator-activated receptor alpha | / | 0.456 | |
1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.456 | |
1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.456 | |
1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.456 | |
1ydr | IQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
2r3i | SCF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2vrb | NAP | Triphenylmethane reductase | / | 0.456 | |
2xiy | XIY | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.456 | |
3c4z | ADP | Rhodopsin kinase | / | 0.456 | |
3ez2 | ADP | Plasmid partition protein A | / | 0.456 | |
3ox3 | 4X4 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.456 | |
3r7v | Z02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.456 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.456 | |
1ndz | FR5 | Adenosine deaminase | 3.5.4.4 | 0.455 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.455 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
2pul | ACP | Methylthioribose kinase | 2.7.1.100 | 0.455 | |
2qmz | LDP | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.455 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.455 | |
3anx | MTA | Polyamine aminopropyltransferase | / | 0.455 | |
3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.455 | |
3djk | G55 | Gag-Pol polyprotein | 3.4.23.16 | 0.455 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
3pj8 | 404 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3py0 | SU9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.455 | |
3zrl | ZRL | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.455 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
4ite | TEY | Vitamin D3 receptor | / | 0.455 | |
4k6z | 1Q3 | Tyrosine-protein kinase JAK1 | / | 0.455 | |
4kla | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.455 | |
4nm5 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.455 | |
5dr2 | ATP | Aurora kinase A | 2.7.11.1 | 0.455 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
1t85 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.454 | |
2c6i | DT1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
2z97 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.454 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3eej | 53R | Uncharacterized protein | / | 0.454 | |
3i0r | RT3 | Gag-Pol polyprotein | 2.7.7.49 | 0.454 | |
3kjr | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.454 | |
3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.454 | |
3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.454 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
4dqu | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
4fkp | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
4kne | 1CY | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.454 | |
1bim | 0QB | Renin | 3.4.23.15 | 0.453 | |
1hii | C20 | Gag-Pol polyprotein | / | 0.453 | |
1j39 | UPG | DNA beta-glucosyltransferase | / | 0.453 | |
1oiq | HDU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.453 | |
1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.453 | |
2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.453 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.453 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.453 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
2zlc | VDX | Vitamin D3 receptor | / | 0.453 | |
3dey | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.453 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.453 | |
3klm | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.453 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3lxi | CAM | Cytochrome P450 | / | 0.453 | |
3pbz | F02 | Endothiapepsin | 3.4.23.22 | 0.453 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
3tea | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.453 | |
4a9u | A9U | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
4af3 | VX6 | Aurora kinase B | 2.7.11.1 | 0.453 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.453 | |
4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.453 | |
4x5j | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
5a9s | NAP | Putative dehydrogenase | / | 0.453 | |
1ke8 | LS4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
2ovh | AS0 | Progesterone receptor | / | 0.452 | |
2qbl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.452 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.452 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.452 | |
3i81 | EBI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.452 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.452 | |
3otb | DGT | Probable tRNA(His) guanylyltransferase | 2.7.7.79 | 0.452 | |
3pre | 3RE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
3qzi | X72 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3sqw | ANP | ATP-dependent RNA helicase MSS116, mitochondrial | 3.6.4.13 | 0.452 | |
3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.452 | |
3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.452 | |
3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
4b4w | 9L9 | Bifunctional protein FolD | / | 0.452 | |
4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
4fkq | 42K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.452 | |
4tnb | SGV | G protein-coupled receptor kinase 5 | 2.7.11.16 | 0.452 | |
4y3q | F02 | Endothiapepsin | 3.4.23.22 | 0.452 | |
4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.452 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.452 | |
1ai9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1ao8 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1bzf | TMQ | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.451 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.451 | |
2azy | CHD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.451 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.451 | |
2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.451 | |
2hb7 | O1C | Vitamin D3 receptor | / | 0.451 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.451 | |
2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.451 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.451 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
3bqc | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
3d8v | UD1 | Bifunctional protein GlmU | / | 0.451 | |
3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.451 | |
3q9w | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
3zon | IK1 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.451 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.451 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.451 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.451 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
4n57 | ADP | APH(2'')-Id | / | 0.451 | |
4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.451 | |
4y35 | F90 | Endothiapepsin | 3.4.23.22 | 0.451 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.451 | |
1cbf | SAH | Cobalt-precorrin-4 C(11)-methyltransferase | 2.1.1.271 | 0.450 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.450 | |
1iwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2jf9 | OHT | Estrogen receptor | / | 0.450 | |
2qbo | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
2zaw | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
3c13 | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
3dg8 | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.450 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.450 | |
3ii4 | 3II | Dihydrolipoyl dehydrogenase | 1.8.1.4 | 0.450 | |
3iqe | F42 | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.450 | |
3nhw | ZXZ | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.450 | |
3nu5 | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
3pd3 | A3T | Threonine--tRNA ligase | 6.1.1.3 | 0.450 | |
3qly | 55V | Uncharacterized protein | / | 0.450 | |
3rpo | 24Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3uxy | NAD | Short-chain dehydrogenase/reductase SDR | / | 0.450 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.450 | |
4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
4c3r | ACP | Aurora kinase A | 2.7.11.1 | 0.450 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.450 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.450 | |
4iir | ANP | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.450 | |
4iql | FMN | Enoyl-(Acyl-carrier-protein) reductase II | / | 0.450 | |
4jvl | EST | Estrogen sulfotransferase | 2.8.2.4 | 0.450 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.450 | |
4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.450 | |
4rw6 | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.450 | |
5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.450 | |
1cde | DZF | Phosphoribosylglycinamide formyltransferase | / | 0.449 | |
1cjk | FOK | Adenylate cyclase type 2 | / | 0.449 | |
1cjk | FOK | Adenylate cyclase type 5 | / | 0.449 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1hk5 | T44 | Serum albumin | / | 0.449 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.449 | |
1rd4 | L08 | Integrin alpha-L | / | 0.449 | |
1w2x | RCP | Acetyl-CoA carboxylase | / | 0.449 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.449 | |
2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2gqp | PA7 | Endoplasmin | / | 0.449 | |
2h2q | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.449 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.449 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
2qbm | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
2r3w | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
2rqf | JH3 | Hemolymph juvenile hormone binding protein | / | 0.449 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
3a25 | SAM | tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase | / | 0.449 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.449 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.449 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
3iqf | E4M | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.449 | |
3mqe | 416 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.449 | |
3och | 2MX | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
3owl | 19E | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.449 | |
3q92 | XNB | Ketohexokinase | / | 0.449 | |
3s43 | 478 | Protease | / | 0.449 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.449 | |
3uxh | UXH | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.449 | |
3vet | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.449 | |
4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.449 | |
4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.449 | |
4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.449 | |
4ktk | KTK | Cytochrome P450 | / | 0.449 | |
4mwh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
4nm7 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.449 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
1dhf | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
1enz | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
1ie9 | VDX | Vitamin D3 receptor | / | 0.448 | |
1mvs | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.448 | |
2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
2feu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
2lfo | GCH | Fatty acid-binding protein, liver | / | 0.448 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
2uzt | SS3 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.448 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
2ybo | SAH | Methyltransferase | / | 0.448 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
3bc3 | OPT | Cathepsin L1 | 3.4.22.15 | 0.448 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.448 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
3pm0 | BHF | Cytochrome P450 1B1 | / | 0.448 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
3s79 | ASD | Aromatase | 1.14.14.14 | 0.448 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.448 | |
3zt0 | ZT0 | Integrase | / | 0.448 | |
4awq | 592 | Heat shock protein HSP 90-alpha | / | 0.448 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
4ifc | ADP | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.448 | |
4ivd | 15T | Tyrosine-protein kinase JAK1 | / | 0.448 | |
4l49 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
4l4e | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.448 | |
1aj8 | COA | Citrate synthase | / | 0.447 | |
1cde | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.447 | |
1dg8 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1ohr | 1UN | V-1 PROTEASE protein | / | 0.447 | |
1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.447 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.447 | |
1uyr | D1L | Acetyl-CoA carboxylase | / | 0.447 | |
1yin | CM3 | Estrogen receptor | / | 0.447 | |
1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.447 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.447 | |
2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
2oax | SNL | Mineralocorticoid receptor | / | 0.447 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
2w9h | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
2z3u | CRR | Cytochrome P450 | / | 0.447 | |
2zdu | 446 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.447 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.447 | |
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.447 | |
3lm9 | ADP | Putative fructokinase | 2.7.1.4 | 0.447 | |
3ns2 | PYV | Abscisic acid receptor PYL2 | / | 0.447 | |
3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.447 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.447 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
3qqg | X06 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3upk | UD1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.447 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.447 | |
4a9r | RU5 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
4dpd | DHF | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.447 | |
4f7l | 0SO | Cyclin-dependent kinase 8 | 2.7.11.22 | 0.447 | |
4g47 | TZF | Mycocyclosin synthase | 1.14.21.9 | 0.447 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
4gnc | ASO | Regucalcin | 3.1.1.17 | 0.447 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
5d4v | SAH | Uncharacterized protein MJ0489 | / | 0.447 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.447 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.447 | |
3qak | UKA | Adenosine receptor A2a | / | 0.447 | |
1dr2 | TAP | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.446 | |
1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.446 | |
1l4e | RBZ | Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase | 2.4.2.21 | 0.446 | |
1llw | FMN | Ferredoxin-dependent glutamate synthase 2 | 1.4.7.1 | 0.446 | |
1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.446 | |
1pxk | CK3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.446 | |
2d4e | NAD | 5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenaseiheyensis HTE831] | / | 0.446 | |
2ds1 | 1CD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
2ham | C33 | Vitamin D3 receptor | / | 0.446 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.446 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
2xs0 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.446 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.446 | |
3bqd | DAY | Glucocorticoid receptor | / | 0.446 | |
3eb0 | DRK | Uncharacterized protein | / | 0.446 | |
3hp2 | P36 | Mitogen-activated protein kinase 14 | / | 0.446 | |
3irn | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.446 | |
3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.446 | |
3meg | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.446 | |
3pd4 | A3G | Threonine--tRNA ligase | 6.1.1.3 | 0.446 | |
3vew | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.446 | |
4a6c | QG9 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
4eos | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
4m6j | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
4u7w | NDP | MxaA | / | 0.446 | |
4ux9 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.446 | |
1a8g | 2Z4 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1bdl | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1db1 | VDX | Vitamin D3 receptor | / | 0.445 | |
1dhj | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
1geb | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
1hsh | MK1 | Gag-Pol polyprotein | / | 0.445 | |
1mb9 | ATP | Carboxyethyl-arginine beta-lactam-synthase | 6.3.3.4 | 0.445 | |
1q8u | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
2cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
2hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.445 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.445 | |
2zoq | 5ID | Mitogen-activated protein kinase 3 | 2.7.11.24 | 0.445 | |
2zui | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
3a1l | 2CC | Cytochrome P450 | / | 0.445 | |
3igg | EFQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3ime | BZ2 | Pantothenate synthetase | 6.3.2.1 | 0.445 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.445 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.445 | |
3r8u | Z31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3uxe | 465 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.445 | |
3wrm | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
4b8l | A0P | Aurora kinase B-A | 2.7.11.1 | 0.445 | |
4b8z | NAP | GDP-L-fucose synthase | 1.1.1.271 | 0.445 | |
4cf7 | ADP | Adenylate kinase | / | 0.445 | |
4ema | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
4g1d | 0VK | Vitamin D3 receptor A | / | 0.445 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
4l4f | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
4o71 | CPB | Bromodomain-containing protein 4 | / | 0.445 | |
5cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
1cs4 | FOK | Adenylate cyclase type 2 | / | 0.444 | |
1cs4 | FOK | Adenylate cyclase type 5 | / | 0.444 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.444 | |
1fmj | RTL | Retinol dehydratase | / | 0.444 | |
1hos | PHP | Gag-Pol polyprotein | / | 0.444 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.444 | |
1prc | UQ1 | Reaction center protein L chain | / | 0.444 | |
1q4u | 4CA | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.444 | |
1rbz | KT5 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.444 | |
1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.444 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.444 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.444 | |
1xny | BTN | Propionyl-CoA carboxylase complex B subunit | / | 0.444 | |
1yt9 | OIS | Gag-Pol polyprotein | / | 0.444 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.444 | |
1z1r | HBH | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
2cjp | VPR | Epoxide hydrolase | / | 0.444 | |
2jkq | VG8 | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.444 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.444 | |
3a3b | RBF | Lumazine protein | / | 0.444 | |
3blq | ATP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.444 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.444 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.444 | |
3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.444 | |
3inv | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.444 | |
3mb7 | 14I | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.444 | |
3tiz | 3TI | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.444 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.444 | |
3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.444 | |
3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.444 | |
4azw | ATP | O-antigen chain terminator bifunctional methyltransferase/kinase WbdD | / | 0.444 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
4bhz | Z0B | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
4eop | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.444 | |
4iq7 | 1G9 | Mycocyclosin synthase | 1.14.21.9 | 0.444 | |
4kgm | ATP | Uncharacterized protein | / | 0.444 | |
4l4b | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
4nmb | FAD | Bifunctional protein PutA | / | 0.444 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.444 | |
4qer | STL | Phospholipase A2 VRV-PL-VIIIa | / | 0.444 | |
4x5h | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.444 | |
4yx6 | FMN | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.444 | |
1bpj | UMP | Thymidylate synthase | / | 0.443 | |
1cjt | FOK | Adenylate cyclase type 2 | / | 0.443 | |
1cjt | FOK | Adenylate cyclase type 5 | / | 0.443 | |
1v9a | SAH | Uncharacterized protein | / | 0.443 | |
1wbv | LI3 | Mitogen-activated protein kinase 14 | / | 0.443 | |
1wxy | FRK | Adenosine deaminase | 3.5.4.4 | 0.443 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.443 | |
2a1n | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
2bl9 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.443 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.443 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.443 | |
2pqz | G0G | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
2qhy | MZ1 | Gag-Pol polyprotein | / | 0.443 | |
2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.443 | |
3a4v | NAD | NDP-sugar epimerase | / | 0.443 | |
3ajr | NAD | NDP-sugar epimerase | / | 0.443 | |
3c1x | CKK | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
3em6 | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3hk1 | B64 | Fatty acid-binding protein, adipocyte | / | 0.443 | |
3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.443 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
3lq5 | SLQ | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.443 | |
3nhf | VVV | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.443 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.443 | |
3nu3 | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3w0j | T08 | Vitamin D3 receptor | / | 0.443 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.443 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.443 | |
4c9p | CAM | Cytochrome P450 | / | 0.443 | |
4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.443 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4fi1 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
4h4q | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.443 | |
4i1n | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
4jsj | QJ7 | Nitric oxide synthase, brain | 1.14.13.39 | 0.443 | |
4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.443 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.443 | |
4ocv | ANP | Aminoglycoside phosphotransferase | / | 0.443 | |
4oth | DRN | Serine/threonine-protein kinase N1 | / | 0.443 | |
4q71 | FAD | Bifunctional protein PutA | / | 0.443 | |
4y8w | STR | Steroid 21-hydroxylase | / | 0.443 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.443 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.443 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.443 | |
5hi6 | MTX | Dihydrofolate reductase | / | 0.443 | |
1j3k | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.442 | |
1osv | CHC | Bile acid receptor | / | 0.442 | |
1rb2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1txi | TX5 | Vitamin D3 receptor | / | 0.442 | |
2a5u | QYT | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
2e9z | UTP | Genome polyprotein | / | 0.442 | |
2fsz | OHT | Estrogen receptor beta | / | 0.442 | |
2har | OCC | Vitamin D3 receptor | / | 0.442 | |
2ok7 | FAD | Ferredoxin--NADP reductase, apicoplast | / | 0.442 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
3dj4 | UD1 | Bifunctional protein GlmU | / | 0.442 | |
3ey9 | TDP | Pyruvate dehydrogenase [ubiquinone] | 1.2.5.1 | 0.442 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.442 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.442 | |
3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.442 | |
3o73 | O73 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.442 | |
3oxv | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
3rai | X85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3rpr | 25Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3um6 | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.442 | |
3vn2 | TLS | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4d58 | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
4dqh | 017 | Gag-Pol polyprotein | / | 0.442 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.442 | |
4f9c | 0SX | Cell division cycle 7-related protein kinase | 2.7.11.1 | 0.442 | |
4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4hbg | NDP | 3-oxoacyl-[acyl-carrier-protein] reductase | 1.1.1.100 | 0.442 | |
4im0 | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.442 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.442 | |
4l43 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.442 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.442 | |
4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
4wlu | NAD | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.442 | |
4xiv | ACP | Chemotaxis protein CheA | 2.7.13.3 | 0.442 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.442 | |
1bdr | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
1d2s | DHT | Sex hormone-binding globulin | / | 0.441 | |
1ml6 | GBX | Glutathione S-transferase A2 | 2.5.1.18 | 0.441 | |
1ndy | FR3 | Adenosine deaminase | 3.5.4.4 | 0.441 | |
1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.441 | |
1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.441 | |
1qxo | FMN | Chorismate synthase | / | 0.441 | |
1v7a | FRC | Adenosine deaminase | 3.5.4.4 | 0.441 | |
1yrc | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
2fxd | DR7 | Pol polyprotein | / | 0.441 | |
2hb8 | MVD | Vitamin D3 receptor | / | 0.441 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.441 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
2r5q | 1UN | Gag-Pol polyprotein | / | 0.441 | |
2uzw | SS4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
2x4f | 16X | Myosin light chain kinase family member 4 | 2.7.11.1 | 0.441 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2znp | K55 | Peroxisome proliferator-activated receptor delta | / | 0.441 | |
3dok | GWJ | Pol protein | / | 0.441 | |
3n5v | XFH | Nitric oxide synthase, brain | 1.14.13.39 | 0.441 | |
3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
3ori | AGS | Serine/threonine protein kinase | / | 0.441 | |
3qar | QAR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
3qgt | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.441 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
3qx4 | X4B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3s7a | 684 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.441 | |
3u8k | 09P | Acetylcholine-binding protein | / | 0.441 | |
3v1n | HPK | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase | 3.7.1.8 | 0.441 | |
3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.441 | |
4b13 | X25 | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.441 | |
4dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4g2g | TDH | Mycocyclosin synthase | 1.14.21.9 | 0.441 | |
4ijp | 1EH | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.441 | |
4l44 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.441 | |
4l4d | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
4m87 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.441 | |
4wh3 | ATP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.441 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
4z9g | 1Q5 | Corticotropin-releasing factor receptor 1 | / | 0.441 | |
1dr3 | TAP | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
1q1r | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.440 | |
1rx7 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1sgu | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
1uum | AFI | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.440 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.440 | |
2gmh | FAD | Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial | 1.5.5.1 | 0.440 | |
2gu8 | 796 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
2hc4 | VDX | Vitamin D3 receptor A | / | 0.440 | |
2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.440 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
2vtr | LZB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.440 | |
3a14 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.440 | |
3byz | H11 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
3cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
3eek | 53S | Uncharacterized protein | / | 0.440 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3nxx | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
3o0i | P54 | Heat shock protein HSP 90-alpha | / | 0.440 | |
3qfv | NM7 | Serine/threonine-protein kinase MRCK beta | 2.7.11.1 | 0.440 | |
3slz | 3TL | Putative gag-pro-pol polyprotein | / | 0.440 | |
3um8 | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.440 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
3wrh | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.440 | |
4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.440 | |
4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4j16 | NAD | NAD/NADP transhydrogenase alpha subunit 1 | / | 0.440 | |
4k28 | NAD | Shikimate dehydrogenase family protein | / | 0.440 | |
4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
4qgi | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
4ure | 1PS | Cyclohexanol dehydrogenase | / | 0.440 | |
4wlo | NAI | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.440 | |
4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
4y12 | AGS | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.440 | |
5av0 | 47X | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 |